21695-184 : Razadyne 8 mg/1 Oral Tablet, Film Coated


NDC21695-184
Labeler: Rebel Distributors Corp
Product Type: Human Prescription Drug
Drug Name:  Razadyne
Dosage Form: Oral Tablet, Film Coated
Application #: NDA021169
Rev. Date: 


Appearance:


Markings: JANSSEN;G;4
Shapes:  Round
Colors:  White
Size (mm): 6
Segments: * 1

* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines.

NDC Package Codes:

  • 21695-184-30: 30 TABLET, FILM COATED IN 1 BOTTLE (21695‑184‑30)

Active Ingredients:

  • Galantamine Hydrobromide

Dosage Strength:

  • 8 mg

Inactive Ingredients:

  • Silicon Dioxide
  • Crospovidone
  • Hypromelloses
  • Lactose Monohydrate
  • Magnesium Stearate
  • Cellulose, Microcrystalline
  • Propylene Glycol
  • Talc
  • Titanium Dioxide
  • Ferric Oxide Red

Pharmaceutical Classes:

  • Cholinesterase Inhibitor [EPC]
  • Cholinesterase Inhibitors [MoA]

Related Products:

Based on records with the same trade name.
  • 21695-591 Razadyne 12 mg (Galantamine Hydrobromide 15.379 mg) Oral Tablet by Rebel Distributors Corp
  • 50458-387 24 Hr Razadyne ER 8 mg Extended Release Capsule by Janssen Pharmaceuticals, Inc.
  • 50458-388 24 Hr Razadyne ER 16 mg Extended Release Capsule by Janssen Pharmaceuticals, Inc.
  • 50458-389 Razadyne ER 24 mg 24hr Extended Release Capsule by Janssen Pharmaceuticals, Inc.
  • 50458-396 Razadyne 4 mg Oral Tablet by Janssen Pharmaceuticals, Inc.
  • 50458-397 Razadyne 8 mg Oral Tablet by Janssen Pharmaceuticals, Inc.
  • 50458-398 Razadyne 12 mg (Galantamine Hydrobromide 15.379 mg) Oral Tablet by Janssen Pharmaceuticals, Inc.
  • 50458-490 Razadyne 4 mg/ml Oral Solution by Janssen Pharmaceuticals, Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 21695-184 QR Code

< Prev: 21695-183Next: 21695-185 >

Related Discussions:

razadyne IR
40mg tabs...




Notice: The MedsChat® NDC Database compiles publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.


Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 24 December 2015.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA